Cellular and molecular bases of B-cell clonal expansions

Clinical and Experimental Rheumatology

Volumn 14, Issue SUPPL. 14, 1996, Pages

  Dolcetti, R ^a   Boiocchi, M ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

Antigen; Autoimmunity; B lymphocytes; Clonality; Infiltratiag T lymphocytes; Lymphomagenesis

Indexed keywords

AUTOIMMUNITY; B LYMPHOCYTE; CONFERENCE PAPER; HUMAN; LYMPHOCYTE CLONE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; LYMPHOMA; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; AUTOIMMUNITY; B-LYMPHOCYTES; CLONE CELLS; HUMANS; IMMUNITY, CELLULAR; LYMPHOCYTES, TUMOR-INFILTRATING; LYMPHOMA, B-CELL; MOLECULAR BIOLOGY;

EID: 0029869855     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (101)

1. LUDWIG CU, GENCIK M, SHIPMAN R: Multistep transformation in low-grade lymphoproliferative diseases. Ann Oncol 1993; 4: 825-30.
2. GAIDANO G, DALLA FAVERA R: Biologic and molecular characterization of non-Hodgkin's lymphoma. Curr Opin Oncol 1993; 5: 776-84.
3. HARRIS NL, JAFFE ES, STEIN H, BANKS PM, CHAN JK, CLEARY ML, DELSOL G, DE WOLF PEETERS C, FALINI B, GATTER KC, et al.: A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-92.
4. ERSBOLL J, SCHULTZ HB, PEDERSEN BJERGAARD J, NISSEN NI: Follicular low-grade non-Hodgkin's lymphoma: long-term outcome with or without tumor progression. Eur J Haematol 1989; 42: 155-63.
5. ZELENETZ AD, CHEN TT, LEVY R: Histologic transformation of follicular lymphoma to diffuse lymphoma represents tumor progression by a single malignant B cell. J Exp Med 1991; 173: 197-207.
6. CLEARY ML, SKLAR J: Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci USA 1985; 82: 7439-43.
7. BAKHSHI A, JENSEN JP, GOLDMAN P, WRIGHT JJ, MCBRIDE OW, EPSTEIN AL, KORSMEYER SJ: Cloning the chromosomal breakpoint of t(14;18) human lymphomas: Clustering around J(H) on chromosome 14 and near a transcriptional unit on 18. Cell 1985; 41: 899-906.
8. MCDONNELL TJ, DEANE N, PLATT FM, NUNEZ G, JAEGER U, MCKEARN JP, KORSMEYER SJ: bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 1989; 57: 79-88.
9. LEE JT, INNES DJ, JR, WILLIAMS ME: Sequential bcl-2 and c-myc oncogene rearrangements associated with the clinical transformation of non-Hodgkin's lymphoma. J Clin Invest 1989; 84: 1454-9.
10. SHAM RL, PHATAK P, CARIGNAN J, JANAS J, OLSON JP: Progression of follicular large cell lymphoma to Burkitt's lymphoma. Cancer 1989; 63: 700-2.
11. LUST JA: Role of cytokines in the pathogenesis of monoclonal gammopathies. Mayo Clin Proc 1994; 69: 691-7.
12. BARLOGIE B, EPSTEIN J, SELVANAYAGAM P, ALEXANIAN R: Plasma cell myeloma - new biological insights and advances in therapy. Blood 1989; 73: 865-79.
13. COTTER FE: Molecular pathology of lymphomas. Cancer Surv 1993; 16: 157-74.
14. AISENBERG AC: Coherent view of non-Hodgkin's lymphoma. J Clin Oncol 1995; 13: 2656-75.
15. KLEIN G: Epstein-Barr virus strategy in normal and neoplastic B cells. Cell 1994; 77: 791-3.
16. CRAIG FE, GULLEY ML, BANKS PM: Post-transplantation lymphoproliferative disorders. Am J Clin Pathol 1993; 99: 265-76.
17. HERNANDEZ AM, SHIBATA D: Epstein-Barr Virus-associated non-Hodgkin's lymphoma in HIV-infected patients. Leuk Lymphoma 1995; 16: 217-21.
18. BIEMER JJ: Malignant lymphomas associated with immunodeficiency states. Ann Clin Lab Sci 1990; 20: 175-91.
19. HSU SM, WALDRON JW JR, HSU PL, HOUGH AJ: Cytokines in malignant lymphomas: review and prospective evaluation. Hum Pathol 1993; 24: 1040-57.
20. PELICCI PG, KNOWLES DM, ARLIN ZA, WIECZOREK R, LUCIW P, DINA D, BASILICO C, DALLA FAVERA R: Multiple monoclonal B cell expansions and c-myc oncogene rearrangements in acquired immune deficiency syndrome-related lymphoproliferative disorders. Implications for lymphomagenesis. J Exp Med 1986; 164: 2049-60.
21. SANTANA V, ROSE NR: Neoplastic lymphoproliferation in autoimmune disease: an updated review. Clin Immunol Immunopathol 1992; 63: 205-13.
22. ITOH T, SHIOTA M, TAKANASHI M, HOJO I, SATOH H, MATSUZAWA A, MORIYAMA T, WATANABE T, HIRAI K, MORI S: Engraftment of human non-Hodgkin lymphomas in mice with severe combined immunodeficiency. Cancer 1993; 72: 2686-94.
23. BOIOCCHI M, DOLCETTI R, CARBONE A: Pathogenesis of human reactive-appearing "non-monomorphous" malignant lymphoproliferative disorders: a hypothesis. Tumori 1992; 78: 221-7.
24. KNOWLES DM: Biologic aspects of AIDS-associated non-Hodgkin's lymphoma. Curr Opin Oncol 1993; 5: 845-51.
25. HESS AD, TUTSCHKA PJ, SANTOS GW: Effect of cyclosporin A on human lymphocyte responses in vitro. J Immunol 1982; 128: 355-9.
26. ELLIOT JF, LINE Y, MIZEL SB, BLEACKLEY RC, HARNISH DG, PAETKAU V: Induction of IL-2 mRNA inhibited by cyclosporine A. Science 1984; 226: 1439-41.
27. KRONKE M, LEONARD WJ, DEPPER JM, ARYA SK, WONG STAAL F, GALLO RC, WALDMANN TA, GREENE WC: Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription. Proc Natl Acad Sci USA 1984; 81: 5214-8.
28. DE VITA S, FERRACCIOLI G, DE RE V, DOLCETTI R, CARBONE A, BARTOLI E, BOIOCCHI M: The polymerase chain reaction detects B cell clonalities in patients with Sjögren's syndrome and suspected malignant lymphoma. J Rheumatol 1994; 21: 1497-501.
29. KAMEL OW, VAN DE RIJN M, HANASONO MM, WARNKE RA: Immunosuppression-associated lymphoproliferative disorders in rheumatic patients. Leuk Lymphoma 1995; 16: 363-8.
30. BAHLER DW, LEVY R: Clonal evolution of a follicular lymphoma: evidence for antigen selection. Proc Natl Acad Sci USA 1992; 89: 6770-4.
31. ZELENETZ AD, CHEN TT, LEVY R: Clonal expansion in follicular lymphoma occurs subsequent to antigenic selection. J Exp Med 1992; 176: 1137-48.
32. FRIEDMAN DF, CHO EA, GOLDMAN J, CARMACK CE, BESA EC, HARDY RR, SILBERSTEIN LE: The role of clonal selection in the pathogenesis of an autoreactive human B cell lymphoma. J Exp Med 1991; 174: 525-37.
33. STEWART AK, SCHWARTZ RS: Immunoglobulin V regions and the B cell. Blood 1994; 83: 1717-30.
34. HUSSELL T, ISAACSON PG, SPENCER J: Proliferation and differentiation of tumour cells from B-cell lymphoma of mucosa-associated lymphoid tissue in vitro. J Pathol 1993; 169: 221-7.
35. FORD RJ, KOUTTAB NM, SAHASRABUDDHE CG, DAVIS FM, MEHTA SR: Growth factor-mediated proliferation in B cell non-Hodgkin's lymphomas. Blood 1985; 65: 1335-41.
36. VAN ENDERT PM, HEILIG B, HAMMERLING GJ, MOLDENHAUER G: Monoclonal antibodies to idiotype inhibit in vitro growth of human B-cell lymphomas. Blood 1992; 79: 129-37.
37. BLASER MJ, PARSONNET J. Parasitism by the "slow" bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J Clin Invest 1994; 94: 4-8.
38. PASCUAL M, PERRIN L, GIOSTRA E, SCHIFFERLI JA: Hepatitis C virus in patients with cryoglobulinemia type II. J Infect Dis 1990; 162: 569-7.
39. FERRI C, GRECO F, LONGOMBARDO G, PALLA P, MORETTI A, MARZO E, FOSELLA PV, PASERO G, BOMBARDIERI S: Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia. Arthritis Rheum 1991; 34: 1606-10.
40. AGNELLO V, CHUNG RT, KAPLAN LM: A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327: 1490-5.
41. ABEL G, ZHANG QX, AGNELLO V: Hepatitis C virus infection in type II mixed cryoglobulinemia. Arthritis Rheum 1993; 36: 1341-9.
42. DAMMACCO F, SANSONNO D, CORNACCHIULO V, MENNUNI C, CARBONE R, LAULETTA G, IACOBELLI AR, RIZZI R: Hepatitis C virus infection and mixed cryoglobulinemia: a sinking association. Int J Clin Lab Res 1993; 23: 45-9.
43. DE VITA S, SANSONNO D, DOLCETTI R, FERRACCIOLI G, CARBONE A, CORNACCHIULO V, SANTINI G, CROVATTO M, GLOGHINI A, DAMMACCO F et al.: Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia. Blood 1995; 86: 1887-92.
44. DE VITA S, SANSONNO D, DOLCETTI R, ZAGONEL V, FERRACCIOLI G, CORNACCHIULO V, IACOBELLI AR, MANCINELLI M, SACCO C, PIVETTA B, et al.: Hepatitis C virus (HCV)-associated B-cell lymphoproliferative disorders. Arthritis Rheum 1995, 38: S200 (abstr. 283).
45. GOREVIC PD, FRANGIONE B. Mixed cryoglobulinemia cross-reactive idiotypes: implications for the relationship of MC to rheumatic and lymphoproliferative diseases. Semin Hematol 1991; 28: 79-94.
46. DIGHIERO G, HART S, LIM A, BORCHE L, LEVY R, MILLER RA: Autoantibody activity of immunoglobulins isolated from B-cell follicular lymphomas. Blood 1991; 78: 581-5.
47. KIPPS TJ, CARSON DA: Autoantibodies in chronic lymphocytic leukemia and related systemic autoimmune diseases. Blood 1993; 81: 2475-87.
48. HUSSELL T, ISAACSON PG, CRABTREE JE, DOGAN A, SPENCER J: Immunoglobulin specificity of low grade B cell gastrointestinal lymphoma of mucosa-associated lymphoid tissue (MALT) type. Am J Pathol 1993; 142: 285-92.
49. GREINER A, MARX A, HEESEMANN J, LEEBMANN J, SCHMAUSSER B, MULLER HERMELINK HK: Idiotype identity in a MALT-type lymphoma and B cells in Helicobacter pylori associated chronic gastritis. Lab Invest 1994; 70: 572-8.
50. DIGHIERO G: Natural autoantibodies in humans: their relevance in autoimmunity and lymphoproliferative disorders. Trends Exp Clin Med 1995; 5: 58-71.
51. NEPOM GT, ERLICH H: MHC class-II molecules and autoimmunity. Annu Rev Immunol 1991; 9: 493-525.
52. LEPAGE V, LAMM LU, CHARRON D: Molecular aspects of HLA class II and some autoimmune diseases. Eur J Immunogen 1993; 20: 153-64.
53. ISAACSON PG: Lymphomas of mucosa associated lymphoid tissue (MALT-type lymphomas). Trends Exp Clin Med 1993; 3: 234-45.
54. FORD RJ, TAMAYO A, LI DJ, CABANILLAS F: Human B cell lymphomas: in vitro and in vivo studies on growth factors and cell growth. Leuk Lymphoma 1993; 10 Suppl: 51-6.
55. BOIOCCHI M, DOLCETTI R, DE RE V, GLOGHINI A, CARBONE A: Demonstration of a unique Epstein-Barr virus-positive cellular clone in metachronous multiple localizations of Hodgkin's disease. Am J Pathol 1993; 142: 33-8.
56. FRISAN T, SJOBERG J, DOLCETTI R, BOIOCCHI M, DE RE V, CARBONE A, BRAUTBAR C, BATTAT S, BIBERFELD P, ECKMAN M, et al.: Local suppression of Epstein-Barr virus (EBV)-specific cytotoxicity in biopsies of EBV-positive Hodgkin's disease. Blood 1995; 86: 1493-501.
57. DOLCETTI R, FRISAN T, SJOBERG J, DE CAMPOS LIMA PO, PISA P, DE RE V, GLOGHINI A, RIZZO S, MASUCCI MG, BOIOCCHI M: Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease. Cancer Res 1995; 55: 3675-81.
58. BOIOCCHI M, DOLCETTI R, DE RE V, CARBONE A, GLOGHINI A: Association of Epstein-Barr virus with Hodgkin's disease. In BARBANTI-BRODANO G, BENDINELLI M, and FRIEDMAN H (Eds.): Dna Tumor Viruses: Oncogenic Mechanisms. New York, Plenum Press, 1996: 375-93.
59. PONZIO NM, ALONSO A, ALISAUSKAS RM: Dependence of lymphoma growth on 'reversed immunological surveillance'. Pathol Immunopathol Res 1987; 6: 1-21.
60. PONZIO NM, BROWN PH, THORBECKE GJ: Host-tumor interactions in the SJL lymphoma model. Int Rev Immunol 1988; 1: 273-301.
61. KATZ IR, ASOFSKY A, THORBECKE GJ: Suppression of spontaneous reticulum cell sarcoma development and of syngeneic stimulator cells by anti-mu treatment of SJL/J mice. J Immunol 1980; 125: 1355-9.
62. ROSLONIEC EF JR, GOTTLIEB C, BUTCH AW, LERMAN SP: Comparative growth of SJL/J lymphomas in irradiated and normal SJL/J mice: Cell cycle distribution and tumor cell quantification. J Natl Cancer Inst 1985; 75: 877-83.
63. ALISAUSKAS RM, PONZIO NM: T-helper cell-specific monoclonal antibody inhibits growth of B-cell lymphomas (RCS) in syngeneic SJL/J mice. Fed Proc 1986; 45: 269.
64. ALISAUSKAS RM, PONZIO NM: T-helper-cell-specific monoclonal antibody inhibits growth of B-cell lymphomas in syngeneic SJL/J mice. Cell Immunol 1989; 119: 286-303.
65. PONZIO NM, DAVID CS, SHREFFLER DC, THORBECKE GJ: Properties of reticulum cell sarcomas of SJL/J mice. V. Nature of reticulum cell sarcoma surface antigen which induces proliferation of normal SJL/J cells. J Exp Med 1977; 146: 132-45.
66. BROWN PH, THORBECKE GJ: Characterization of the molecules on SJL/J lymphomas which stimulate syngeneic T cells. J Immunol 1985; 135: 3572-80.
67. DE KRUYFF RH, BROWN PH, THORBECKE GJ, PONZIO NM: Characterization of SJL T cell clones responsive to syngeneic lymphoma (RCS): RCS-specific clones are stimulated by activated B cells. J Immunol 1985; 135: 3581-6.
68. PONZIO NM, LERMAN SP, CHAPMAN JM, THORBECKE GJ: Properties of reticulum cell sarcomas in SJL/J mice. IV. Minimal development of cytotoxic cells despite marked proliferation to syngeneic RCS in vivo and in vitro. Cell Immunol 1977; 32: 10-22.
69. LASKY JL, PONZIO NM, THORBECKE GJ: Characterization and growth factor requirements of SJL lymphomas. I. Development of a B cell growth factor-dependent in vitro cell line, cRCS-X. J Immunol 1988; 140: 679-87.
70. LASKY JL, THORBECKE GJ: Characterization and growth factor requirements of SJL lymphomas. II. Interleukin 5 dependence of the in vitro cell line, cRCS-X, and influence of other cytokines. Eur J Immunol 1989; 19: 365-71.
71. RAMSAY AD, SMITH WJ, ISAACSON PG: T-cell-rich B-cell lymphoma. Am J Surg Pathol 1988; 12: 433-43.
72. DOLCETTI R, CARBONE A, ZAGONEL V, DE RE V, GLOGHINI A, FRISAN T, BOIOCCHI M: Type 2 Epstein-Barr virus genome and latent membrane protein-1 expression in a T-cell-rich lymphoma of probable B-cell lineage. Am J Clin Pathol 1993; 100: 541-9.
73. DOLCETTI R, DE RE V, CARBONE A, DE VITA S, GLOGHINI A, TIRELLI U, PASQUOTTI B, BOIOCCHI M: Genotypic and immunohistological demonstration of the progression of an unusual reactive-like B-cell lymphoproliferative disorder to a high grade diffuse lymphoma. Hum Pathol 1995; 26: 348-54.
74. FARHI DC: T-cell-rich B-cell lymphoma. Reflections on changes in hematopathology. Am J Clin Pathol 1995; 103: 4-5.
75. UMETSU DT, ESSERMAN L, DONLON TA, DEKRUYFF RH, LEVY R: Induction of proliferation of human follicular (B type) lymphoma cells by cognate interaction with CD4+ T cell clones. J Immunol 1990; 144: 2550-7.
76. HUSSELL T, ISAACSON PG, CRABTREE JE, SPENCER J: The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 1993; 342: 571-4.
77. CLARK EA, LEDBETTER JA: How B and T cells talk to each other. Nature 1994; 367: 425-8.
78. TAIEB J, AUFFREDOU MT, VAZQUEZ A: B-T cell interactions modulate inhibitory effects of interleukin-4 on human B cell proliferation. Eur J Immunol 1994; 24: 480-4.
79. HSU SM, XIE SS, WALDRON JA: Functional heterogeneity and pathogenic significance of interleukin-6 in B-cell lymphomas. Am J Pathol 1992; 141: 915-23.
80. CORDINGLEY FT, BIANCHI A, HOFFBRAND AV, REITTIE JE, HESLOP HE, VYAKARNAM A, TURNER M, MEAGER A, BRENNER MK: Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies. Lancet 1988; 1: 969-71.
81. BIONDI A, ROSSI V, BASSAN R, BARBUI T, BETTONI S, SIRONI M, MANTOVANI A, RAMBALDI A: Constitutive expression of the interleukin-6 gene in chronic lymphocytic leukemia. Blood 1989; 73: 1279-84.
82. FREEMAN GJ, FREEDMAN AS, RABINOWE SN, SEGIL JM, HOROWITZ J, ROSEN K, WHITMAN JF, NADLER LM: Interleukin 6 gene expression in normal and neoplastic B cells. J Clin Invest 1989; 83: 1512-8.
83. SUZUKI H, YASUKAWA K, SAITO T, GOITSUKA R, HASEGAWA A, OHSUGI Y, TAGA T, KISHIMOTO T: Anti-human interleukin-6 receptor antibody inhibits human myeloma growth in vivo. Eur J Immunol 1992; 22: 1989-93.
84. BENJAMIN D, KNOBLOCH TJ, DAYTON MA: Human B-cell interleukin-10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10. Blood 1992; 80: 1289-98.
85. EMILIE D, TOUITOU R, RAPHAEL M, PEUCHMAUR M, DEVERGNEE O, REA D, COUMBRARAS J, CREVON MC, EDELMAN L, JOAB I, et al.: In vivo production of interleukin-10 by malignant cells in AIDS lymphomas. Eur J Immunol 1992; 22: 2937-42.
86. BAIOCCHI RA, ROSS ME, TAN JC, CHOU CC, SULLIVAN L, HALDAR S, MONNE M, SEIDEN MV, NARULA SK, SKLAR J, et al.: Lymphomagenesis in the SCID-hu mouse involves abundant production of human interleukin-10. Blood 1995; 85: 1063-74.
87. MASOOD R, ZHANG Y, BOND MW, SCADDEN DT, MOUDGIL T, LAW RE, KAPLAN MH, JUNG B, ESPINA BM, LUNARDI ISKANDAR Y, et al.: Interleukin-10 is an autocrine growth factor for acquired immunodeficiency syndrome-related B-cell lymphoma. Blood 1995; 85: 3423-30.
88. DE VITA S, DOLCETTI R, FERRACCIOLI G, PIVETTA B, DE RE V, GLOGHINI A, D'AGOSTO A, BARTOLI E, CARBONE C, BOIOCCHI M: Local cytokine expression in the progression toward B cell malignancy in Sjögren's syndrome. J Rheumatol 1995; 22: 1674-80.
89. YE BH, LO COCO F, CHANG CC, ZHANG J, MIGLIAZZA A, CECHOVA K, KNOWLES DM, OFFIT K, CHAGANTI RS, DALLA FAVERA R: Alterations of the BCL-6 gene in diffuse large-cell lymphoma. Curr Top Microbiol Immunol 1995; 194: 101-8.
90. IMAMURA J, MIYOSHI I, KOEFFLER HP: p53 in hematologic malignancies. Blood 1994; 84: 2412-21.
91. WEINBERG RA: The retinoblastoma protein and cell cycle control. Cell 1995; 81: 323-30.
92. AHUJA HG, JAT PS, FOTI A, BAR ELI M, CLINE MJ: Abnormalities of the retinoblastoma gene in the pathogenesis of acute leukemia. Blood 1991; 78: 3259-68.
93. STRANKS G, HEIGHT SE, MITCHELL P, JADAYEL D, YUILLE MA, DE LORD C, CLUTTERBUCK RD, TRELEAVEN JG, POWLES RL, NACHEVA E, et al.: Deletions and rearrangement of CDKN2 in lymphoid malignancy. Blood 1995; 85: 893-901.
94. GOMBART AF, MOROSETTI R, MILLER CW, SAID JW, KOEFFLER HP: Deletions of the cyclin-dependent kinase inhibitor genes p16INK4A and p15INK4B in non-Hodgkin's lymphomas. Blood 1995; 86: 1534-9.
95. OGAWA S, HANGAISHI A, MIYAWAKI S, HIROSAWA S, MIURA Y, TAKEYAMA K, KAMADA N, OHTAKE S, UIKEN, SHIMAZAKI C, et al.: Loss of the cyclin-dependent kinase 4-inhibitor (p16; MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies. Blood 1995; 86: 1548-56.
96. UCHIDA T, WATANABE T, KINOSHITA T, MURATE T, SAITO H, HOTTA T: Mutational analysis of the CDKN2 (MTS1/p16ink4A) gene in primary B-cell lymphomas. Blood 1995; 86: 2724-31.
97. SANDER CA, YANO T, CLARK HM, HARRIS C, LONGO DL, JAFFE ES, RAFFELD M: p53 mutation is associated with progression in follicular lymphomas. Blood 1993; 82: 1994-2004.
98. LO COCO F, GAIDANO G, LOUIE DC, OFFIT K, CHAGANTI RS, DALLA FAVERA R: p53 mutations are associated with histologic transformation of follicular lymphoma. Blood 1993; 82: 2289-95.
99. FELIX CA, NAU MM, TAKAHASHI T, MITSUDOMI T, CHIBA I, POPLACK DG, REAMAN GH, COLE DE, LETTERIO JJ, WHANG PENG J, et al.: Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemia. J Clin Invest 1992; 89: 640-7.
100. WADA M, BARTRAM CR, NAKAMURA H, HACHIYA M, CHEN DL, BORENSTEIN J, MILLER CW, LUDWIG L, HANSEN HAGGE TE, LUDWIG WD, et al.: Analysis of p53 mutations in a large series of lymphoid hematologic malignancies of childhood. Blood 1993; 82: 3163-9.
101. GAIDANO G, BALLERINI P, GONG JZ, INGHIRAMI G, NERI A, NEWCOMB EW, MAGRATH IT, KNOWLES DM, DALLA FAVERA R: p53 mutation in human lymphoid malignancies associated with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci USA 1991; 88: 5413-7.